Finally, in a secondary analysis, we evaluated the relative prognostic performance of MOFI-FL by comparing it with other established hepatic steatosis indices (FLI, HSI, NAFLD-LFS, and the AST/ALT ratio) using Cox regression models and the concordance index (C-index). The gene discussed is GPT; the disease is metabolic dysfunction-associated steatotic liver disease.